PathoGenesis infectious diseases news

PGNS formed Pathogenesis B.V. (Rotterdam, the Netherlands) to market its TOBI tobramycin in the Netherlands to treat chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients. T...